From Ex Vivo to In Vivo: Advances in Lentiviral Vector Engineering for CAR-T Therapy.
Saved in:
| Title: | From Ex Vivo to In Vivo: Advances in Lentiviral Vector Engineering for CAR-T Therapy. |
|---|---|
| Authors: | Baek Y; Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea., Seo YR; Curocell Inc., Daejeon 34109, Korea., Kim S; Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea., Jung S; Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea., Kim CH; Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Korea.; School of Transdisciplinary Innovations, Seoul National University, Seoul 08826, Korea., Lee YH; Curocell Inc., Daejeon 34109, Korea. |
| Source: | Immune network [Immune Netw] 2026 Feb 23; Vol. 26 (1), pp. e13. Date of Electronic Publication: 2026 Feb 23 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Korean Association of Immunologists Country of Publication: Korea (South) NLM ID: 101137270 Publication Model: eCollection Cited Medium: Print ISSN: 1598-2629 (Print) Linking ISSN: 15982629 NLM ISO Abbreviation: Immune Netw Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
